Role of Gut Microbiota in Breast Cancer and Drug Resistance

Breast cancer is the most common malignancy in women worldwide. The cause of cancer is multifactorial. An early diagnosis and the appropriate treatment of cancer can improve the chances of survival. Recent studies have shown that breast cancer is influenced by the microbiota. Different microbial signatures have been identified in the breast microbiota, which have different patterns depending on the stage and biological subgroups. The human digestive system contains approximately 100 trillion bacteria. The gut microbiota is an emerging field of research that is associated with specific biological processes in many diseases, including cardiovascular disease, obesity, diabetes, brain disease, rheumatoid arthritis, and cancer. In this review article, we discuss the impact of the microbiota on breast cancer, with a primary focus on the gut microbiota's regulation of the breast cancer microenvironment. Ultimately, updates on how immunotherapy can affect the breast cancer-based microbiome and further clinical trials on the breast and microbiome axis may be an important piece of the puzzle in better predicting breast cancer risk and prognosis.

Automated summary

Breast cancer is influenced by the microbiota, which has different patterns in the breast microbiota depending on the stage and biological subgroups. The gut microbiota, as an emerging field of research, is associated with various diseases. This review discusses the impact of the microbiota on breast cancer, focusing on the regulation of the breast cancer microenvironment by the gut microbiota. Updates on immunotherapy and further clinical trials on the breast and microbiome axis may help better predict breast cancer risk and prognosis.